ArticleMedical oncology (Northwood, London, England)2025

DCAF13 influences breast cancer chemotherapy resistance through metabolic reprogramming by regulating c-Myc expression.

Shiqiang Bai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.